Prominent publications by Benedicte Brichard
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
[ PUBLICATION ]
Allogeneic bone marrow transplantation (BMT) from HLA-identical siblings is an accepted treatment for both thalassemia and sickle cell disease (SCD). However, it is associated with decided risk of both transplant-related mortality (TRM) and chronic graft-versus-host disease (GVHD). We analyzed 44 patients (median age, 5 years; range, 1-20 years) given an allogeneic related cord blood transplant for either thalassemia (n = 33) or SCD (n = 11). Thirty children were given cyclosporin A ...
|Known for Blood Transplantation | Cell Disease | Patients Thalassemia | Survival Graft | Gvhd Prophylaxis|
Key People For Sickle Cell Disease
Benedicte Brichard:Expert Impact
Concepts for whichBenedicte Brichardhas direct influence:Sickle cell disease, Blood transplantation, Patients thalassemia, Cell disease, Survival graft, Gvhd prophylaxis, Host disease, Donor engraftment.
Benedicte Brichard:KOL impact
Concepts related to the work of other authors for whichfor which Benedicte Brichard has influence:Cord blood, Sickle cell disease, Cell transplantation, Hematopoietic stem, Thalassemia major, Gvhd prophylaxis, Hla matching.
Is this your profile? Claim your profile Copy URL Embed Link to your profile